Monitor patients during and for an appropriate period of time after administration of benlysta. Benlysta is indicated in addition to standard therapyfor reducing disease activity in adult patients with active, autoantibodypositive, systemic lupus erythematosus sle. Medicare part d coverage criteria benlysta belimumab. Any unused solution in the vials must be discarded. If you will be giving yourself the shot, your doctor or.
Feb 03, 2020 benlysta can cause serious and sometimes fatal side effects such as infections, and heart problems. It also lists the strengths in which benlysta is available. Benlysta will not be used in combination with rituximab, other biologics, or iv cyclophosphamide, and benlysta is prescribed by a rheumatologist, and patient is 18 years of age or older, and physician attestation that the patients clinical status has not deteriorated, and dose does not exceed 10mgkgmonth. Mechanism of action of benlysta diseases home page. Fda approved lupus drugs clinical trials are an incredibly important contribution to new drugs for lupus. Restricted access do not disseminate or copy without approval. Monoclonal antibodies are made to target and destroy only certain cells in the body. Systemic lupus erythematosus sle is the most common form of lupus, a chronic, incurable autoimmune disease producing autoantibodies that can attack. This page of the emedtv web library explains what to do if you miss a dose of benlysta, how to store this lupus medication, and whether it is available in generic form. Medicare does not have a national coverage determination ncd for benlysta belimumab.
Geneva woods nurse to obtain baseline vital signs prior to the start of each benlysta infusion. Benlysta belimumab autoinjector and prefilled syringes are covered under the pharmacy benefit. For the prefilled syringe, insert the entire needle into the pinched area of the skin at a slight 45degree angle using a dartlike motion. It is given as a shot into the fatty part of the skin on the top of the thigh or the belly area. Benlysta belimumab page 3 of 8 unitedhealthcare oxford clinical policy effective 02012020 19962020, oxford health plans, llc background benlysta belimumab is a recombinant human igg1. A healthcare provider may teach you how to properly use the. The aim of conducting this drug use investigation dui in all subjects until data are accumulated from a certain number of subjects after benlysta being marketed, data will be collected on safety and effectiveness of benlysta in an early stage and thereby to take the necessary measures for proper use of benlysta. The company has won fda approval for a subcutaneous version, and that new formula is one reason why.
The efficacy of benlysta has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus. Although i observe a little increase in my symptoms in the week before each infusion, the overall effect of benlysta on my lupus has been a continuing. The pdf file should be the first option within the insert dialog window. After reconstitution, each ml of solution contains 80mg belimumabwith a ph of 6. Belimumab benlysta is a targeted, human monoclonal antibody that binds to soluble b lymphocyte stimulator blys. However, hcpc code j0490 benlysta belimumab is addressed in the articles for.
Intravenous dosing of benlysta is approved for adults and children aged 5 years and older. Inserting a pdf as an image is a quick way to present flat data in a noninteractive fashion. And patient does not have any of the following exclusion criteria. Sections or subsections omitted from the full prescribing information are not. Evaluating the addition to formulary of belimumab for the. Before that there were only three, aspirin, plaquenil and prednisone. This may help to protect healthy cells from damage. Highlights of prescribing information these highlights do not. By binding blys, benlysta inhibits the survival of b cells, including autoreactive b cells, and reduces the differentiation of b cells into immunoglobulinproducing plasma cells. Yesterday brought benlysta infusion number seven for my lupus, and after twentyone weeks, this new biologic drug is producing encouraging effects in controlling my lupus symptoms.
Lupus and benlysta after 21 weeks lupus, the adventure. The consumer medicine information is a leaflet written for people who have been prescribed this product. While keeping your hold on the syringe, slowly move your thumb back, allowing the plunger to rise. Read below to learn more about the clinical trials leading to its approval by the fda. Glaxosmithkline hopes to get its new benlysta formula under lupus patients skinliterally. Benlysta belimumab injectable medication precertification request aetna precertification notification 503 sunport lane, orlando, fl 32809 phone. Glaxosmithkline lupus med benlysta aims for growth.
Insert pdf file content into a powerpoint presentation powerpoint. However, the use of belimumab as addon therapy can complicate. If no central intravenous access, geneva woods nurse to insert peripheral iv per geneva woods pharmacy protocol. Do not use cosentyx if you have had a severe allergic reaction to secukinumab or any of the other ingredients in cosentyx.
If youre creating a microsoft powerpoint presentation, you can insert a pdf document by following these steps. This will allow quick identification of new safety information. Per package insert, the efficacy of benlysta has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus. The safety and efficacy of benlysta have not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus. Benlysta will not be used in combination with rituximab, other biologics, or iv cyclophosphamide, and benlysta is prescribed by a rheumatologist, and patient is 18 years of age or older, and physician attestation that the patients clinical status has not deteriorated, and. A healthcare provider will give you this injection. A pivotal phase iii, randomised, placebocontrolled study of. Effects of belimumab on flare rate and expected damage. Jul 24, 2017 glaxosmithkline hopes to get its new benlysta formula under lupus patients skinliterally. Sle is an inflammatory autoimmune disease, which means that the bodys immune system attacks its own tissues and causes inflammation. To bring you great quality, smallpdf has partnered with solid documents that offers the best conversion out there.
Benlysta belimumab injectable medication precertification. Belimumab comes as a powder to be mixed into a solution to be injected intravenously into a vein in adults and children 5 years of age and older. Although the changes and improvements have not been extremely dramatic, my symptoms have been consistently decreasing and successful partial reduction of daily prednisone dose was achieved. Benlysta belimumab is a monoclonal antibody that affects the actions of the bodys immune system. To assess the efficacy and safety of subcutaneous sc belimumab in patients with. Secondary end points were reduction in the corticosteroid dosage and time to severe flare. If you forget to take your benlysta subcutaneous injection if you miss a dose, inject the next dose as soon as. Tell your caregiver if you feel anxious, nauseated, lightheaded, itchy, or have trouble breathing, severe headache, or skin redness and swelling. Apr 09, 2020 with benlysta, apparently the lupus vs. The related drug information index provides comprehensive access to all drug information related to a specific drug types of content include full prescribing information, drug summaries, full prescribing information continuing medication education full pi cme, medication guides, risk evaluation and mitigation strategies rems summaries, rems continuing medication education rems cme, and. Objective to investigate effectiveness and safety of belimumab in. Benlysta has not been studied in combination with other biologics or intravenous cyclophosphamide. Cvs caremark is an independent company that provides pharmacy benefit management services to carefirst bluecross blueshield and carefirst bluechoice, inc. Highlights of prescribing information these highlights do.
Conclusions in patients with sle from north east asia, belimumab significantly. Belimumab benlysta is a synthetic manmade injectable antibody that reduces the activity of immune cells called bcells in patients with systemic lupus erythematosus sle. Wyeth the drug company took it off the market on its own. What drugs, substances, or supplements interact with benlysta. Benlysta belimumab vials are covered under the medical benefit. In addition, the marketing authorisation holder mah took the opportunity to bring the pi in line with. Consider interrupting benlysta therapy if patients develop a new infection during benlysta treatment. Benlysta is also injected under the skin, usually once per week.
The medicine must be given slowly, and the infusion can take about 1 hour to complete. Push the plunger all the way down until all of the solution is injected. Information for the user benlysta 120 mg powder for concentrate for solution for infusion benlysta 400 mg powder for concentrate for solution for infusion belimumab this medicine is subject to additional monitoring. If your pdf is in a presentation format, the conversion should be no problem. Read the medication guide and instructions for use provided by your pharmacist before you start using belimumab and each time you get a refill. Statistics were performed by the spss package version 21. Subcutaneous dosing of benlysta is only approved for adult patients. Use of benlysta is not recommended in these situations. Hold the prefilled syringe in one hand and use your free hand to gently pinch the skin around the injection site.
On july 20, 2009, human genome sciences and glaxosmithkline announced positive results from their phaseiii, doubleblind, placebocontrolled lupus clinical trial this 52week study, also known as bliss52, enrolled 865 patients. This article further discusses benlystas mechanism of action and provides a link to more detailed information. Gently invert the bag or bottle to mix the solution. Benlysta belimumab autoinjectors and prefilled syringes.
By binding blys, benlysta allows more b cells to undergo the normally occurring process of apoptosis, which inhibits the survival of b cells, including autoreactive b cells and reduces. Insert pdf content into your presentation either as a picture that shows on your slide, or as a document that you can open during your slide show. Keep taking benlysta belimumab autoinjectors and prefilled syringes as you have been told by your doctor or other health care provider, even if you feel well. Use with caution in patients with chronic infections. This information is intended for use in australia only and does not replace advice from a healthcare professional. A pdf document is filled with all kinds of content, including text or images, that you might want to import elsewhere. First approved lupus treatment option benlysta belimumab. Belimumab is a synthetic manmade injectable antibody that reduces the activity of immune cells called bcells in patients with systemic lupus erythematosus.
Each vial contains a sufficient amount of belimumab to deliver 120mg in 1. Benlysta is a prescription medication used to treat patients with active systemic lupus erythematosus sle or lupus who are receiving other lupus medicines. Nov 17, 2010 the drug, which would be given by intravenous infusion every four weeks, is a monoclonal antibody that tamps down the immune system by inhibiting a protein in the body called b lymphocyte stimulator. Benlysta can cause serious and sometimes fatal side effects such as infections, and heart problems. Click the image and it will be inserted into the slide. Doctors give trusted answers on uses, effects, sideeffects, and cautions. Benlysta is available as 120 mg in a 5ml singleuse vial and 400 mg in a 20ml singleuse vial for injection, for intravenous. Benlysta is a sterile, white to off white lyophilized powder in a singleuse vial. Intravenous infusion lyophilized powder for intravenous infusion. Benlysta is given as an infusion into a vein, usually every 2 to 4 weeks. Cosentyx secukinumab is a prescription medicine used to treat adults. Benlysta should be administered by healthcare providers prepared to manage anaphylaxis. Jan 22, 2020 it is given as a shot into the fatty part of the skin on the top of the thigh or the belly area. In the insert object box, select create from file, and then enter the pdf file location.
Benlysta prior authorization form if this is an urgent request, please call upmc health plan pharmacy services. Efficacy and safety of subcutaneous belimumab in systemic lupus. The information was added in the codes section as the following. Then add the required volume of the reconstituted solution of benlysta into the infusion bag or bottle.
As this emedtv page explains, benlysta works to treat lupus by binding to and blocking the action of a certain antigen. A read is counted each time someone views a publication summary such as the title, abstract, and list of authors, clicks on a figure, or views or downloads the fulltext. Carefirst bluecross blueshield is the shared business name of carefirst of maryland, inc. See the medication guide for a complete list of ingredients. Wyeth states it was not for safety reasons or that it was not effective. The quality of the pdf file is reduced with this method, but you can open the full pdf file by doubleclicking the image when viewing or editing in normal view. Benlysta is indicated as addon therapy in adult patients with. Cosentyx is a medicine that affects your immune system. The safety and efficacy of benlysta have not been evaluated in patients with severe active lupus nephritis or.
Benlysta belimumab infusion orders geneva woods nurse to infuse benlysta over one hour via peripheral or central access. The recommended dosage regimen for benlysta is 10 mgkg at 2week intervals for the first 3 doses and at 4week intervals thereafter. Gsk receives fda approval for a new selfinjectable. Benlysta is used to treat active systemic lupus erythematosus sle in adults and children aged five years. Get emergency medical help if you have signs of an allergic reaction. Benlysta sq belimumab prior auth criteria proprietary information. It is ideal for presenting data contained within other. Glaxosmithkline lupus med benlysta aims for growth injection. Local coverage determinations lcds do not exist at this time.
The company has won fda approval for a subcutaneous version, and. This article further discusses benlysta s mechanism of action and provides a link to more detailed information. Belimumab benlysta physician order sheet drug allergies. Approvals may be subject to dosing limits in accordance with fdaapproved labeling, accepted compendia, andor evidencebased practice guidelines. Benlysta subcutaneous injection must not be injected into a vein intravenously.
Insert the entire needle into the pinched area of the skin at a slight 45degree angle using a dartlike motion. Belimumab also comes as a solution liquid in an autoinjector or prefilled syringe to inject subcutaneously under the skin in adults. Open powerpoint and display the slide where you want to insert the pdf text. Systemic lupus erythematosus sle is the most common form of lupus, a chronic, incurable autoimmune disease producing autoantibodies. Gsk receives european marketing authorisation for self.
Parts of the body affected by sle include the heart, skin, joints, kidneys, lungs, and brain. Before we begin, you should be aware of the two ways you can do this. My prednisone dose is down, and my pain, fatigue, cognitive disruption, and other symptoms are still improving. Insert pdf file content into a powerpoint presentation. The drug, which would be given by intravenous infusion every four weeks, is a monoclonal antibody that tamps down the immune system by inhibiting a protein in. Medical billing codes may not be used for benlysta injections for subcutaneous use. The thought is it that wyeth did not want to have to deal with potential side effects and possible law suits like bextra and vioxx went through. Before 2011, there had not been any new fda approved drugs for systemic lupus in over 50 years. Gsk announced today that the us food and drug administration fda has approved a new subcutaneous formulation of benlysta belimumab for the treatment of adult patients with active, autoantibody positive sle who are receiving standard therapy. Benlysta belimumab dose, indications, adverse effects.
890 1266 154 557 1347 1620 1205 1144 241 1420 141 679 925 1275 527 142 792 297 664 428 1492 694 972 791 1382 1466 133 350 425 812 1296 12